Intravenously delivered IL-2 with picomolar affinity to EIIIB had only a modest impact on tumor growth compared to untargeted IL-2 in two different tumor models (Fig. 3).We have previously showed that the biodistribution of large format IL-2 immunocytokines is dominated by the IL-2 moiety (5). The gene discussed is IL2; the disease is neoplasm.